Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2008
10/15/2008CN100425703C MHC-B-LB gene PCR-RFLP/abel relative to chicken egg productivity
10/14/2008US7435874 Expresion vector comprising nucleotide sequences coding resistance protein (R1) for use as tool in generating transgenic tomato with fungal resistance; disease resistant plants; biological pest control
10/14/2008US7435873 Identification of soybeans having resistance to Phytophthora sojae
10/14/2008US7435872 Role of p62 in aging-related disease
10/14/2008US7435870 administering nucleic acids to fish and detecting changes in messenger RNA in the cells, tissues or organs using a cDNA microarray, in response to the nucleic acids; screening drugs for neovscularization, apoptosis or toxic activity
10/14/2008US7435868 sod-3 gene promoter element is of great advantage for the identifying genes or compounds that modulate the activity of the transcription factor DAF-2/insulin receptor pathway; transgenic C. elegans (caenorhabditis elegans); does not depend on C. elegans dauer larvae which took several days
10/14/2008US7435807 Amplicon for use as reporter tool in transgenic, insect resistant, corn
10/14/2008US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences
10/14/2008US7435794 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435589 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
10/14/2008US7435583 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells
10/14/2008US7435578 Apparatus comprising membrane components for use in screen, identifying and separating preferential particles in bodily fluids
10/14/2008US7435577 Using membrane impregnated with reagents which take advantage of varying surface charge densities to monitor low density lipoprotein concentration of erythrocytes
10/14/2008US7435574 Whole cell catalyst which expresses lactobacillus oxidase for use in generating/producing chrial enantiomer-enriched organic compounds
10/14/2008US7435572 Methods and compositions for DNA manipulation
10/14/2008US7435570 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/14/2008US7435569 Method of forming a molded protein matrix for use in a sensor
10/14/2008US7435559 Methods and compositions employing a novel stearoyl-CoA desaturase-hSCD5
10/14/2008US7435558 determination of lactic acid and/or lactate in saliva and to a method for the location-specific determination of the patient-related risk of caries
10/14/2008US7435557 Incubating, with compound, a fungal GTP cyclohydrolase II, allowing binding to the fungal GTP cyclohydrolase II polypeptide; selecting one candidate compound which binds to the fungal GTP cyclohydrolase ll; selecting compound which reduces or blocks the activity of the fungal GTP cyclohydrolase II
10/14/2008US7435556 For increasing the ratio of the pHBA ester glucoside to total pHBA glucose conjugates in pHBA-producing microorganisms and green plant cells using nucleic acid fragments encoding plant glucosyltransferases that exhibit catalytic activity with p-hydroxybenzoic acid (pHBA) as a substrate
10/14/2008US7435555 Using asparagine hydroxylase to identify modulators which act on the caspase-activated dnase (CAD) domain of hypoxia inducible factors (HIF) for use in treatment of tumors and ischemic disease
10/14/2008US7435552 Binding assays that use human T1R2 to identify potential taste modulators
10/14/2008US7435548 Induction or inflammation in humans; obtain cells, incubate with cytokines, monitor inflammation in humans
10/14/2008US7435547 Injectable or oral administration of a drug with an active ingredient of an extract from inflamed cutaneous tissue of rabbits inoculated with vaccinia virus; side effect reduction
10/14/2008US7435546 System to detect inducible translocation
10/14/2008US7435545 Method for sizing polynucleotides using electrophoresis with non-DNA size standards
10/14/2008US7435543 Screening and propagation of swine genomes with heat resistance phenotypes; analyzing nucleotide polymorphism in gene to calibrate fat thickness
10/14/2008US7435542 Exhaustive selection of RNA aptamers against complex targets
10/14/2008US7435541 Restriction enzyme genotyping
10/14/2008US7435539 Typing of human enteroviruses
10/14/2008US7435538 Using cell-free protein synthesis system with the use of wheat embryo extract solution; inhibitor to Severe Acute Respiratory Syndrome (SARS) 3CLpro
10/14/2008US7435419 Methods of diagnosing and treating pre-eclampsia or eclampsia
10/14/2008US7435339 Filter device integrating sampled volume control
10/14/2008CA2288821C Modulation of human mast cell activation
10/14/2008CA2273204C Fen-1 endonucleases, mixtures and cleavage methods
10/14/2008CA2157200C Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
10/14/2008CA2155503C A method for detecting defects in protein c/protein s mediated blood clotting
10/14/2008CA2115276C Reagent compositions for analytical testing
10/12/2008CA2625480A1 Detecting prostate cancer
10/09/2008WO2008122035A1 In vivo tumor targeting and spectroscopic detection with surface-enhanced raman nanoparticle tags
10/09/2008WO2008122007A1 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists
10/09/2008WO2008122002A2 Organism identification panel
10/09/2008WO2008121927A1 Measurement of an insoluble analyte in a sample
10/09/2008WO2008121911A2 Software for design and verification of synthetic genetic constructs
10/09/2008WO2008121867A1 Mrna interferase from myxococcus xanthus
10/09/2008WO2008121840A1 Development of diagnostic markers from the saliva of head and neck cancer patients
10/09/2008WO2008121828A2 Methods of macromolecular analysis using nanochannel arrays
10/09/2008WO2008121802A2 Lipoprotein lipase and its effect on statin treatments
10/09/2008WO2008121797A1 Fxdy5 modulators for treating, diagnosing, and detecting cancer
10/09/2008WO2008121788A2 Haplotypes of lipoprotein lipase, visceral adiposity and fasting insulin levels
10/09/2008WO2008121727A1 Identification of the causative mutation for hereditary equine regional dermal asthenia and a method for testing same
10/09/2008WO2008121444A2 Genetic methods for speciating campylobacter
10/09/2008WO2008121384A1 Source tagging and normalization of dna for parallel dna sequencing, and direct measurement of mutation rates using the same
10/09/2008WO2008121375A2 Modified surfaces for immobilization of active molecules
10/09/2008WO2008121374A2 Systems and methods for enhancing fluorescent signals
10/09/2008WO2008121296A1 Diagnostic methods and kits for functional disorders
10/09/2008WO2008121291A1 Utility of snp markers associated with major soybean plant maturity and growth habit genomic regions
10/09/2008WO2008121250A1 Calibration and normalization method for biosensors
10/09/2008WO2008121132A2 Gene expression profiling for identification, monitoring, and treatment of prostate cancer
10/09/2008WO2008121125A1 Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
10/09/2008WO2008121121A2 Plasmid dna isolation
10/09/2008WO2008120831A1 Dnp63a gene and screening methods of anticancer agent by using it
10/09/2008WO2008120659A1 Method of determining or estimating plant characteristics using gene expression data
10/09/2008WO2008120614A1 Humor ingredient measuring apparatus
10/09/2008WO2008120216A1 Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease
10/09/2008WO2008120027A1 Primer composition and a kit useful for the identification of phyllanthus
10/09/2008WO2008119974A1 Diagnostic markers of wound infection
10/09/2008WO2008119838A1 Fto gene polymorphisms associated to obesity and/or type ii diabetes
10/09/2008WO2008119802A1 Deletion bearing bard1 isoforms and use thereof
10/09/2008WO2008119776A1 Methods for the prognosis or for the diagnosis of a thyroid disease
10/09/2008WO2008119775A1 In vitro method for diagnosing male infertility
10/09/2008WO2008119767A2 Method of nucleic acid analysis.
10/09/2008WO2008119765A1 Method of nucleic acid analysis to analyze the methylation pattern of cpg islands in different samples
10/09/2008WO2008119562A1 Method and kits for detection of egfrviii
10/09/2008WO2008119539A2 Modified polynucleotides comprising ribose rings
10/09/2008WO2008119507A1 Timp-4 as a biomarker for the diagnosis of cardiac insufficiency
10/09/2008WO2008119488A1 Alkyl amines improve detection of components of formaldehyde-fixed biological samples
10/09/2008WO2008119470A1 Device for performing multiple analyses in parallel
10/09/2008WO2008119360A1 Amiloride sensitive sodium channels associated with panic disorders
10/09/2008WO2008119332A2 Method for the detection of paratuberculosis
10/09/2008WO2008119195A1 Methods to identify modulators
10/09/2008WO2008119190A1 Microfluidic platforms for genotyping
10/09/2008WO2008119181A1 Stabilized gold nanoparticles and methods of making the same
10/09/2008WO2008119170A1 Method of determining risk of scoliosis
10/09/2008WO2008102057A9 Method and test kit for determining the amounts of target sequences and nucleotide variations therein
10/09/2008WO2008102038A3 Method and product for 'in vitro' genotyping with applications in anti-ageing medicine
10/09/2008WO2008101089A3 A method of monitoring microbiological activity in process streams
10/09/2008WO2008100627A3 The secreted protein ccdc80 regulates adipocyte differentiation
10/09/2008WO2008100582A3 Spectroscopic system and method for predicting outcome of disease
10/09/2008WO2008100145A3 Method for selection of bovines producing milk with improved fatty acid composition
10/09/2008WO2008097841A3 Surface chemistry and deposition techniques
10/09/2008WO2008097349A3 Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes
10/09/2008WO2008097277A3 Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
10/09/2008WO2008097268A8 Apparatus and method for detection of trace chemicals
10/09/2008WO2008095122A3 Methods of reducing 15-f2t-isop levels in mammals
10/09/2008WO2008094202A3 Methodology for detection, enumeration, propagation and manipulation of bacteriophages
10/09/2008WO2008091701A3 Use of anti-egfr antibodies in treatment of egfr mutant mediated disease
10/09/2008WO2008088865A3 Antisense and pretargeting optical imaging